XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.1
Contingent Consideration - Reconciliation of the Beginning and Ending Balances Related to the Contingent Consideration (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Balance at December 31, 2021 $ 80,477  
Milestone payments (25,000)  
Change in fair value recognized in earnings 665  
Balance at March 31, 2022 (unaudited) 56,142  
Contingent consideration, current portion 46,890 $ 44,840
Contingent consideration, long-term 9,252 35,637
Contingent consideration 56,142 $ 80,477
Regulatory and developmental contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration 46,890  
Sales-based contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration 9,252  
USWM Acquisition    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Balance at December 31, 2021 70,170  
Milestone payments (25,000)  
Change in fair value recognized in earnings 1,720  
Balance at March 31, 2022 (unaudited) 46,890  
Contingent consideration 46,890  
USWM Acquisition | Regulatory and developmental contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration 46,890  
USWM Acquisition | Sales-based contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration 0  
Adamas Acquisition    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Balance at December 31, 2021 10,307  
Milestone payments 0  
Change in fair value recognized in earnings (1,055)  
Balance at March 31, 2022 (unaudited) 9,252  
Contingent consideration 9,252  
Adamas Acquisition | Regulatory and developmental contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration 0  
Adamas Acquisition | Sales-based contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration $ 9,252